This is why the hit came as this has become obviou
Post# of 144882
![](/assets/46931549/no_avatar_available_thumb.jpg)
Also attracting attention is biotech CytoDyn, which has now reached the requisite number of patients in its Phase 3 trial of leronlimab for COVID-19 ...
https://finance.yahoo.com/news/wednesday-pre-...13771.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)